Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Entering text into the input field will update the search result below LITS Lite Strategy, Inc. Earnings Date & History Follow 7.64K followers $1.18 -0.025 (-2.08%) 12:35 PM 03/26/26 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results